Michael Goldberg Net Worth & Insider Trades

Michael Goldberg - Director, Navidea Biopharmaceuticals, Inc

As of July 7, 2016

What is Michael Goldberg's Net Worth?

The current estimated net worth of Navidea Biopharmaceuticals, Inc's Director, Michael Goldberg, is estimated to be about $290.76K . Michael Goldberg owns about 289,711 units of Navidea Biopharmaceuticals, Inc common stock. In the last 3 years at Navidea Biopharmaceuticals, Inc, Michael Goldberg has sold an estimated value of $0 worth.

What is Michael Goldberg's Past Insider Trading?

Michael Goldberg's largest purchase order was 100,000 units , worth over $107.74K on November 17, 2014. In total, Michael Goldberg has made about 9 transactions over 3 years of their time at Navidea Biopharmaceuticals, Inc. Michael Goldberg usually trades in November, with the busiest year in 2015 and 2014.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Michael M Goldberg

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Michael Goldberg's' Mailing Address?

  • Mailing address is C/o Montaur Capital Partners 152 West 57th Street, 4th Floor New York NY 10019 NY

What are Navidea Biopharmaceuticals, Inc's Past Insider Trades?

Navidea Biopharmaceuticals, Inc's most recent insider trade came on June 15, 2023 by John K. Scott Jr. BY Power of Attorney who bought 990 units worth $0 . In the last 11 years, insiders at Navidea Biopharmaceuticals, Inc have sold an estimated value of $11.81M and bought an estimated value of $8.24M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are John K. Scott Jr., BY Power of Attorney,  Malcolm G Witter, Director,  and Brent Larson, EVP .

NAVIDEA BIOPHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...